港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医药外包概念

2,744.137

+87.8173.31%

涨家数：5

跌家数：3

平家数：- -

市盈率：- -

高：2,749.705

开：2,654.626

低：2,609.270

收：2,656.319

数据加载中...

每日卖空追踪 | 金斯瑞生物科技 07月24日卖空量成交143.6万股，卖空比例为4.26%

昭衍新药07月24日获主力加仓949.7万元

维亚生物07月24日获主力加仓19.8万元

康龙化成07月24日获主力加仓3874.4万元

神州细胞(688520.SH)子公司产品SCT640C获得药物临床试验批准

CRO的局部复苏

中国医药创新促...

药明生物上半年利润预增超五成多家预告盈利大增 CXO板块走出低谷？

药明生物涨4% 料中期净利同比增长约56%

泰格医药盘中异动下午盘快速拉升5.06%

医疗服务行业盘中拉升，普蕊斯涨7.68%

药明康德盘中异动早盘快速上涨3.01%报95.950港元

药明生物盘中异动股价大涨3.30%

港股异动 | 开拓药业-B(09939.HK)盘中涨超7% 治疗中国男性脱发药物临床试验II期达到主要终点

港股异动 | 云顶新耀(01952)涨超3% EVM14临床试验申请获受理为自研mRNA平台首个实现“中美双报”产品

【湾区早参】广州上半年货物贸易进出口总额首次突破6000亿；东莞今年上半年GDP同比增长4.8%

重发-BRIEF-中国药明生物称预计上半年收益将增长16%，净利同比增56%

药明生物拟8月19日举行董事会会议批准中期业绩

药明生物发盈喜，预期上半年归属于公司权益股东的利润同比增长约56%

药明生物：预期与去年同期比较上半年收益增长约16%

开拓药业-B(09939)：KX- 826 酊1.0%治疗中国成年男性雄激素脱发关键性临床试验II期阶段达到主要终点

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1576/news?page=7"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"医药外包概念","latestPrice":2744.1365,"timestamp":1753852767201,"preClose":2656.319,"halted":0,"volume":133143726,"delay":0,"changeRate":0.03306,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":87.817383,"latestTime":"07-30 13:19:27","open":2654.6257,"high":2749.7046,"low":2609.2703,"amount":4540239150,"amplitude":0.052868,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1753863000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1753839000000,1753848000000],[1753851600000,1753862400000]],"pbRate":3.235946,"peRate":14.282494,"turnoverRate":0.011743,"increases":5,"decrements":3,"flats":0,"marketCap":637125007104,"floatMarketCap":253713406464},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":2749.7046,"amplitude":0.052868,"preClose":2656.319,"low":2609.2703,"pbRate":"3.235946","latestPrice":2744.1365,"volume":133143726,"delay":0,"open":2654.6257,"prevYearClose":1395.7731,"prevWeekClose":2461.148,"prevMonthClose":1988.255,"prevQuarterClose":1988.255,"fiveDayClose":2304.191,"twentyDayClose":2000.645,"sixtyDayClose":1693.116,"secType":"PLATE","market":"HK","turnoverRate":0.011743,"peRate":14.282494,"marketCap":637125007104,"floatMarketCap":253713406464,"timestamp":1753852767201,"nameCN":"医药外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":5,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553365200","title":"每日卖空追踪 | 金斯瑞生物科技 07月24日卖空量成交143.6万股，卖空比例为4.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553365200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553365200?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 16:30","pubTimestamp":1753345825,"startTime":"0","endTime":"0","summary":"金斯瑞生物科技北京时间07月24日，涨0.88%，卖空量成交143.6万股%，较上一交易日减少75.49%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724171919a6bf5d72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724171919a6bf5d72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","HK0000320223.HKD","HK0000306685.HKD","01548","BK1576","HK0000320264.USD","BK1141","HK0000306701.USD"],"gpt_icon":0},{"id":"2553223208","title":"昭衍新药07月24日获主力加仓949.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553223208","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553223208?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 16:15","pubTimestamp":1753344927,"startTime":"0","endTime":"0","summary":"07月24日, 昭衍新药股价涨6.79%，报收22.80元，成交金额1.4亿元，换手率5.15%，振幅7.96%，量比0.93。昭衍新药今日主力资金净流入949.7万元，上一交易日主力净流入1646.6万元。该股近5个交易日上涨4.84%，主力资金累计净流入1803.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2899.3万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165320a460e9e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165320a460e9e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2553084282","title":"维亚生物07月24日获主力加仓19.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553084282","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553084282?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 16:15","pubTimestamp":1753344927,"startTime":"0","endTime":"0","summary":"07月24日, 维亚生物股价涨5.19%，报收1.62元，成交金额2120.3万元，换手率0.63%，振幅5.19%，量比1.47。维亚生物今日主力资金净流入19.8万元，上一交易日主力净流入286.4万元。该股近5个交易日上涨1.89%，主力资金累计净流出122.8万元；近20日主力资金累计净流出473.4万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165322a6bf4e43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165322a6bf4e43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","01873"],"gpt_icon":0},{"id":"2553479206","title":"康龙化成07月24日获主力加仓3874.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553479206","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553479206?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 16:15","pubTimestamp":1753344926,"startTime":"0","endTime":"0","summary":"07月24日, 康龙化成股价涨7.18%，报收20.75元，成交金额4.6亿元，换手率7.60%，振幅6.56%，量比1.21。康龙化成今日主力资金净流入3874.4万元，上一交易日主力净流入9611.8万元。该股近5个交易日上涨12.80%，主力资金累计净流入1.3亿元；近20日主力资金累计净流入2.6亿元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165302a6bf4e16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165302a6bf4e16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","BK1576","BK1141"],"gpt_icon":0},{"id":"2553272086","title":"神州细胞(688520.SH)子公司产品SCT640C获得药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2553272086","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553272086?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 16:02","pubTimestamp":1753344153,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 神州细胞(688520.SH)发布公告，近日，北京神州细胞生物技术集团股份公司控股子公司神州细胞工程有限公司(以下简称“公司”)收到国家药品监督管理局(以下简称“国家药监局”)核准签发的《药物临床试验批准通知书》，同意公司自主研发的产品SCT640C注射液开展成人类风湿关节炎适应症的临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1141","03347","BK1576","688520","BK1583"],"gpt_icon":0},{"id":"2553720942","title":"CRO的局部复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2553720942","media":"中国医药创新促...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553720942?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 15:23","pubTimestamp":1753341825,"startTime":"0","endTime":"0","summary":"而在创新药企取得成果之后，复苏传导至CRO，往往存在时间差。所以比起2021年前的全民盛宴，这更像是一场局部的复苏。因此，CRO的“复苏”必须加上苛刻的定语：仅限于头部 CRO 中押对最新 BD 风向的部门，以及拥有独家适应症优势或技术平台的小而美 CRO，其余同质化的CRO依旧吃不饱。长期来看，无论是Biotech还是CRO，专注于自身最擅长、最有资源禀赋的细分领域，形成差异化优势，对行业整体健康发展更为有利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724155320a6bf2a07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724155320a6bf2a07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","603259","03759","BK1141","03347","BK1574","BK1576","06978","02359"],"gpt_icon":0},{"id":"2553279347","title":"药明生物上半年利润预增超五成 多家预告盈利大增 CXO板块走出低谷？","url":"https://stock-news.laohu8.com/highlight/detail?id=2553279347","media":"澎湃新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553279347?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 14:00","pubTimestamp":1753336802,"startTime":"0","endTime":"0","summary":"【药明生物上半年利润预增超五成 多家预告盈利大增 CXO板块走出低谷？】7月24日早间，药明生物（2269.HK）发布业绩预告称，预计与去年同期比较上半年收益增长约16%；上半年利润及归属于公司权益股东的利润相比于去年同期将分别增长约54%和约56%，毛利率将同比提升约3.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://finance.eastmoney.com/news/1354,202507243466413471.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202507243466413471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["LU0516423174.USD","LU0051755006.USD","LU0417516902.SGD","LU0359202008.SGD","LU0856984785.SGD","LU1880383366.USD","LU0052750758.USD","LU0326950275.SGD","LU0327786744.USD","LU2039709279.SGD","LU0516422952.EUR","LU0516422366.SGD","LU0181495838.USD","LU0588546209.SGD","LU0819121731.USD","LU0979878070.USD","LU0823426480.USD","LU0307460666.USD","LU0320764599.SGD","LU0516423091.SGD","IE00B0JY6N72.USD","BK1589","LU0140636845.USD","LU0417516738.SGD","LU0516422440.USD","LU1688375341.USD","LU0348825331.USD","LU0039217434.USD","LU1242518857.USD","LU0043850808.USD","LU1242518931.SGD","BK1610","LU0456846285.SGD","LU1720050803.USD","SG9999002463.SGD","BK1141","02269","LU0708995583.HKD","LU0348735423.USD","LU0359201612.USD","LU0823426308.USD","BK1521","CXO","LU0456827905.SGD","SG9999002562.SGD","LU1794554557.SGD","BK1576","LU0572944931.SGD"],"gpt_icon":0},{"id":"2553276812","title":"药明生物涨4% 料中期净利同比增长约56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553276812","media":"金吾资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553276812?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 13:36","pubTimestamp":1753335407,"startTime":"0","endTime":"0","summary":"消息面上，药明生物公布，根据对集团截至2025年6月30日止六个月的未经审核综合管理账目的初步评估，集团预期与去年同期比较，截至2025年6月30日止六个月所录得的公司收益将增长约16%；毛利率将同比提升约3.6%；公司截至2025年6月30日止六个月的利润及归属于公司权益股东的利润相比于去年同期将分别增长约54%和约56%；以及经调整股份为基础的薪酬开支、外汇损益及股权投资损益后，公司非国际财务报告准则经调整纯利将增长约11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724133738971b5091&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724133738971b5091&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0819121731.USD","LU0516422952.EUR","LU1242518857.USD","LU0708995583.HKD","LU0456846285.SGD","LU0516423174.USD","LU0039217434.USD","LU0326950275.SGD","LU1242518931.SGD","LU0823426480.USD","LU0043850808.USD","LU0572944931.SGD","IE00B0JY6N72.USD","LU1794554557.SGD","WXIBF","BK1576","LU0052750758.USD","LU0307460666.USD","LU0359201612.USD","BK1589","BK1610","LU0140636845.USD","02269","LU0327786744.USD","LU0516422440.USD","LU0516423091.SGD","LU0051755006.USD","LU0456827905.SGD","LU1720050803.USD","SG9999002463.SGD","LU0417516738.SGD","LU2039709279.SGD","LU0588546209.SGD","LU1688375341.USD","LU0348735423.USD","LU0856984785.SGD","LU0417516902.SGD","BK1141","BK1521","LU0359202008.SGD","LU0181495838.USD","LU0979878070.USD","LU0348825331.USD","LU0320764599.SGD","LU0823426308.USD","LU0516422366.SGD","LU1880383366.USD","SG9999002562.SGD"],"gpt_icon":0},{"id":"2553276844","title":"泰格医药盘中异动 下午盘快速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553276844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553276844?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 13:01","pubTimestamp":1753333307,"startTime":"0","endTime":"0","summary":"2025年07月24日下午盘13时01分，泰格医药股票出现异动，股价大幅拉升5.06%。截至发稿，该股报50.850港元/股，成交量160.374万股，换手率1.30%，振幅4.03%。泰格医药股票所在的生物技术行业中，整体涨幅为1.25%。公告显示，此次共有20余家机构实现退出，包括启明创投、云锋基金、泰格医药、浦东科技创新基金、上海张江燧锋等。其中，云锋基金持股约3%；杭州泰格持股约8.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724130151a6bee50e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724130151a6bee50e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1583","BK1576","03347"],"gpt_icon":0},{"id":"2553273777","title":"医疗服务行业盘中拉升，普蕊斯涨7.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553273777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553273777?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 13:00","pubTimestamp":1753333240,"startTime":"0","endTime":"0","summary":"07月24日，医疗服务行业盘中拉升，截至13点00分，医疗服务行业整体指数上涨2.01%，报6303.870点。从个股上来看，该行业的成分股中，普蕊斯涨7.68%，凯莱英、博腾股份2只股涨幅超过5%。从资金上来看，截止发稿，医疗服务行业主力净流入为-3.30亿，其中药明康德受到资金热捧，主力净流入6833.19万；拉长时间线来看，该板块近20日主力资金净流入-29.86亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724130040971b40d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724130040971b40d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0708995583.HKD","LU0052750758.USD","LU1046422090.SGD","BK1141","BK1576","LU2045819591.USD","LU2242644610.SGD","06821","BK1583","LU2125910500.SGD","LU0320764599.SGD","02359","603259"],"gpt_icon":0},{"id":"2553627845","title":"药明康德盘中异动 早盘快速上涨3.01%报95.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553627845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553627845?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 11:20","pubTimestamp":1753327219,"startTime":"0","endTime":"0","summary":"2025年07月24日早盘11时20分，药明康德股票出现异动，股价快速上涨3.01%。截至发稿，该股报95.950港元/股，成交量366.258万股，换手率0.95%，振幅3.01%。资金方面，该股资金流入1.76247亿港元，流出1.26248亿港元。药明康德股票所在的生物技术行业中，整体涨幅为0.42%。翰宇药业近日发布的2025年半年度业绩预告显示，公司预计上半年实现归母净利润1.42亿元至1.62亿元，同比增长1470.82%至1663.89%。而在此之前，翰宇药业扣非净利润已连亏7年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724112020a46052f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724112020a46052f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU2242644610.SGD","LU1046422090.SGD","BK1141","LU2045819591.USD","LU2125910500.SGD","02359","LU0052750758.USD","BK1576","LU0320764599.SGD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2553220638","title":"药明生物盘中异动 股价大涨3.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553220638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553220638?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 10:44","pubTimestamp":1753325092,"startTime":"0","endTime":"0","summary":"2025年07月24日早盘10时44分，药明生物股票出现异动，股价大幅拉升3.30%。截至发稿，该股报29.700港元/股，成交量2733.92万股，换手率0.67%，振幅4.35%。药明生物股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，奥星生命科技、圣诺医药-B、中国抗体-B涨幅较大，振幅较大的相关个股有奥星生命科技、同源康医药-B、迈博药业-B，振幅分别为24.18%、19.45%、17.31%。期内，公司利润及归属于公司权益股东的利润预计将分别同比增长约54%和约56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724104452a4604159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724104452a4604159&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0516423174.USD","LU2039709279.SGD","LU0456846285.SGD","LU0516422366.SGD","BK1610","BK1521","LU0819121731.USD","LU1688375341.USD","SG9999002562.SGD","LU0348825331.USD","LU0326950275.SGD","LU1242518857.USD","LU0348735423.USD","LU0588546209.SGD","BK1141","LU0052750758.USD","02269","LU0051755006.USD","LU0823426308.USD","LU0039217434.USD","LU0181495838.USD","LU0516423091.SGD","LU0417516738.SGD","LU0307460666.USD","LU0359201612.USD","LU0572944931.SGD","LU1794554557.SGD","IE00B0JY6N72.USD","BK1589","LU0979878070.USD","LU1720050803.USD","LU0417516902.SGD","SG9999002463.SGD","LU1880383366.USD","LU0516422440.USD","LU0359202008.SGD","LU0320764599.SGD","LU0043850808.USD","BK1576","LU0456827905.SGD","LU0516422952.EUR","LU1242518931.SGD","LU0140636845.USD","LU0823426480.USD","LU0856984785.SGD","LU0327786744.USD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2553222088","title":"港股异动 | 开拓药业-B(09939.HK)盘中涨超7% 治疗中国男性脱发药物临床试验II期达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222088","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553222088?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 10:10","pubTimestamp":1753323003,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","BK1574","BK1161","BK1141","09939","03347","BK1515","BK1583"],"gpt_icon":0},{"id":"2553222300","title":"港股异动 | 云顶新耀(01952)涨超3% EVM14临床试验申请获受理 为自研mRNA平台首个实现“中美双报”产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222300","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553222300?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 09:48","pubTimestamp":1753321723,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，云顶新耀涨超3%，截至发稿，涨3.54%，报73.2港元，成交额1.15亿港元。消息面上，7月15日，云顶新耀宣布，其通用型的现货肿瘤治疗性疫苗EVM14注射液的新药临床试验申请获国家药品监督管理局药品审评中心的正式受理。作为云顶新耀首款自研mRNA肿瘤治疗性疫苗，EVM14在临床前研究中展现出巨大治疗潜力。同时，EVM14还能够诱导免疫记忆，展现出有效降低肿瘤复发及转移的能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321330.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK1161","BK1141","BK1583","BK1574","01952","03347"],"gpt_icon":0},{"id":"2553222996","title":"【湾区早参】广州上半年货物贸易进出口总额首次突破6000亿；东莞今年上半年GDP同比增长4.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222996","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553222996?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 08:25","pubTimestamp":1753316706,"startTime":"0","endTime":"0","summary":"根据广东省地区生产总值统一核算结果，2025年上半年，东莞市地区生产总值6067.84亿元，按不变价格计算，同比增长4.8%。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1962756","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03931","LU0708995583.HKD","LU0320764755.SGD","CYB","LU0594300419.USD","UCmain","LU2125910500.SGD","LU0052750758.USD","LU0516422366.SGD","IE00BFXG1179.USD","LU0181495838.USD","LU0228659784.USD","LU0823426308.USD","MUCmain","LU0516423174.USD","HK0000320223.HKD","LU0348825331.USD","LU0417516902.SGD","02550","LU0543330483.HKD","LU2045819591.USD","LU1794554557.SGD","LU0328353924.USD","02269","LU1880383366.USD","HK0000306701.USD","LU0823426480.USD","IE0009570106.USD","LU0385154629.USD","02319","00020","LU0072462343.USD","LU0327786744.USD","LU0128522157.USD","LU0228367735.SGD","LU1769817179.HKD","LU0651946864.USD","CNHmain","BK1109","LU1242518931.SGD","80020","LU0819121731.USD","LU0456846285.SGD","BK4588","LU0856984785.SGD","LVS","BK1576","MCNHmain","LU0417516738.SGD"],"gpt_icon":1},{"id":"2553222622","title":"重发-BRIEF-中国药明生物称预计上半年收益将增长16%，净利同比增56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222622","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553222622?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 08:03","pubTimestamp":1753315412,"startTime":"0","endTime":"0","summary":"重发-BRIEF-中国药明生物称预计上半年收益将增长16%，净利同比增56%重发以补上标题前半句百分号路透7月24日 - WuXi Biologics (Cayman) Inc 2269.HK:中国药明生物称预计上半年收益将增长约16%；毛利率将同比提升约3.6%；预计上半年利润及归属于公司权益股东的利润同比分别增长约54%和56%。浏览详情，请点击此处 (发稿 崔珠珠) ((Zhuzhu.Cui@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nL4T3TL00G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0039217434.USD","SG9999002463.SGD","LU1794554557.SGD","IE00B0JY6N72.USD","LU0456846285.SGD","02269","LU2039709279.SGD","LU0516423091.SGD","LU0043850808.USD","LU0516422952.EUR","BK1141","SG9999002562.SGD","LU0572944931.SGD","LU0140636845.USD","LU1242518857.USD","LU1880383366.USD","LU0979878070.USD","BK1589","LU0856984785.SGD","LU0708995583.HKD","LU0307460666.USD","LU0181495838.USD","LU0348825331.USD","BK1576","BK1610","LU1688375341.USD","LU0320764599.SGD","LU0348735423.USD","LU0456827905.SGD","LU1720050803.USD","LU0516422366.SGD","LU0588546209.SGD","LU0516422440.USD","LU0417516902.SGD","LU0359201612.USD","LU0823426480.USD","LU0326950275.SGD","LU0051755006.USD","LU0359202008.SGD","LU0052750758.USD","LU0516423174.USD","LU0327786744.USD","LU0417516738.SGD","LU0823426308.USD","BK1521","LU0819121731.USD","LU1242518931.SGD"],"gpt_icon":0},{"id":"2553801226","title":"药明生物拟8月19日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2553801226","media":"格隆汇","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553801226?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 07:19","pubTimestamp":1753312797,"startTime":"0","endTime":"0","summary":"格隆汇7月24日丨药明生物(02269.HK)宣布，公司谨订于2025年8月19日（星期二）在香港举行董事会会议，藉以（其中包括）考虑及批准集团截至2025年6月30日止六个月的中期业绩及其刊发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724072010971ab4bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724072010971ab4bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0140636845.USD","LU1242518931.SGD","BK1576","SG9999002562.SGD","LU0417516738.SGD","LU0456827905.SGD","LU0348735423.USD","LU0456846285.SGD","LU0708995583.HKD","LU1880383366.USD","LU0307460666.USD","LU0348825331.USD","LU0516423091.SGD","LU0819121731.USD","02269","BK1521","LU0359202008.SGD","LU1720050803.USD","LU0359201612.USD","LU1688375341.USD","IE00B0JY6N72.USD","LU0181495838.USD","LU0516422952.EUR","LU0052750758.USD","LU0320764599.SGD","LU0516422366.SGD","LU0823426308.USD","LU1794554557.SGD","BK1610","LU0417516902.SGD","LU1242518857.USD","LU0856984785.SGD","LU2039709279.SGD","LU0516423174.USD","LU0588546209.SGD","LU0979878070.USD","LU0823426480.USD","LU0051755006.USD","LU0326950275.SGD","LU0572944931.SGD","LU0327786744.USD","BK1141","BK1589","LU0043850808.USD","WXIBF","LU0039217434.USD","LU0516422440.USD","SG9999002463.SGD"],"gpt_icon":0},{"id":"2553225058","title":"药明生物发盈喜，预期上半年归属于公司权益股东的利润同比增长约56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553225058","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553225058?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 07:08","pubTimestamp":1753312137,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明生物 公布，该集团预期于2025年上半年取得的收益同比将增长约16%;毛利率将同比提升约3.6%;利润及归属于公司权益股东的利润相比于去年同期将分别增长约54%和约56%;以及经调整股份为基础的薪酬开支、外汇损益及股权投资损益后，公司非国际财务报告准则经调整纯利将增长约11%。","market":"hk","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321269.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物发盈喜，预期上半年归属于公司权益股东的利润同比增长约56%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1880383366.USD","LU0140636845.USD","LU1242518931.SGD","LU0856984785.SGD","LU0456846285.SGD","LU2039709279.SGD","BK1521","IE00B0JY6N72.USD","LU0326950275.SGD","LU0051755006.USD","LU0327786744.USD","LU0979878070.USD","LU0516422366.SGD","LU0039217434.USD","LU0359201612.USD","LU0588546209.SGD","LU0181495838.USD","LU0516422952.EUR","LU0516423091.SGD","LU1720050803.USD","LU1794554557.SGD","SG9999002463.SGD","LU0516423174.USD","LU0823426308.USD","LU0708995583.HKD","LU0348825331.USD","LU0819121731.USD","SG9999002562.SGD","LU0043850808.USD","LU0456827905.SGD","BK1589","LU0307460666.USD","LU0320764599.SGD","BK1610","LU0417516902.SGD","LU0572944931.SGD","BK1576","LU0359202008.SGD","LU0052750758.USD","LU0823426480.USD","BK1141","02269","LU0417516738.SGD","LU1242518857.USD","LU0348735423.USD","LU0516422440.USD","LU1688375341.USD"],"gpt_icon":1},{"id":"2553225706","title":"药明生物：预期与去年同期比较上半年收益增长约16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553225706","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553225706?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 07:08","pubTimestamp":1753312135,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0516422440.USD","SG9999002562.SGD","LU0039217434.USD","BK1589","LU0348825331.USD","LU0417516738.SGD","LU0043850808.USD","LU0320764599.SGD","LU0326950275.SGD","LU0588546209.SGD","LU0348735423.USD","LU0856984785.SGD","LU1242518857.USD","LU1880383366.USD","LU2039709279.SGD","LU0819121731.USD","LU0359202008.SGD","LU1242518931.SGD","LU0516422366.SGD","LU0051755006.USD","LU0456846285.SGD","LU0516422952.EUR","LU0417516902.SGD","BK1141","LU0708995583.HKD","LU0359201612.USD","LU0327786744.USD","LU0823426480.USD","LU0181495838.USD","LU0516423174.USD","LU0307460666.USD","LU1688375341.USD","LU0052750758.USD","LU0456827905.SGD","LU1720050803.USD","BK1521","LU1794554557.SGD","LU0140636845.USD","HEXmain","IE00B0JY6N72.USD","LU0516423091.SGD","LU0979878070.USD","02269","BK1610","LU0823426308.USD","LU0572944931.SGD","BK1576","SG9999002463.SGD"],"gpt_icon":0},{"id":"2553922531","title":"开拓药业-B(09939)：KX- 826 酊1.0%治疗中国成年男性雄激素脱发关键性临床试验II期阶段达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2553922531","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553922531?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 06:15","pubTimestamp":1753308950,"startTime":"0","endTime":"0","summary":"智通财经APP讯，开拓药业-B 公布，其自主研发、潜在同类首创的 KX-826 酊 1.0%治疗脱发的关键性临床试验 II 期阶段已获得顶线数据。该项关键性临床试验是一项多中心、随机、双盲、赋形剂对照的 II/III 期适应性设计研究，用以评估 KX-826 酊 1.0%和 0.5%外用治疗中国成年男性 AGA 患者的有效性和安全性。与安慰剂组相比，0.5% BID组和 1.0% BID 组均显示出统计学显著的 疗效优势及临床意义 。KX-826 酊在临床试验显示出令人满意的安全性和耐受性，整体不良事件发生率低。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","BK1583","BK1161","BK1574","03347","09939","BK1515"],"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":7,"totalSize":236,"code":"91000000","status":"200"}]}}